- Investing Ideas
- /
- U.S. Healthcare Large Cap High Growth Potential
U.S. Healthcare Large Cap High Growth Potential
Results
8
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
8 companies
Hims & Hers Health
Market Cap: US$10.8b
Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
HIMS
US$48.96
7D
2.1%
1Y
136.6%
DexCom
Market Cap: US$32.5b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$83.76
7D
0.2%
1Y
-24.4%
Solventum
Market Cap: US$13.2b
A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
SOLV
US$75.08
7D
-3.6%
1Y
56.4%
Baxter International
Market Cap: US$15.2b
Through its subsidiaries, provides a portfolio of healthcare products in the United States.
BAX
US$30.66
7D
-1.8%
1Y
-9.9%
Cencora
Market Cap: US$58.6b
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
COR
US$298.03
7D
0.9%
1Y
34.0%
Veeva Systems
Market Cap: US$45.9b
Provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
VEEV
US$280.63
7D
-0.8%
1Y
54.0%
Boston Scientific
Market Cap: US$153.6b
Develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
BSX
US$102.41
7D
-2.3%
1Y
33.9%
Stryker
Market Cap: US$150.0b
Operates as a medical technology company.
SYK
US$389.50
7D
-1.8%
1Y
16.1%